奈良宣言（ALT over 30）のMASLD（metabolic dysfunction-associated steatotic liver disease）における臨床的意義の検証 Importance of ALT levels of >30 in patients with MASLD: Nara Declaration 2023 Miwa Kawanaka , Hideki Fujii , Michihiro Iwaki , Hideki Hayashi , Hidenori Toyoda , Satoshi Oeda , Hideyuki Hyogo , Asahiro Morishita , Kensuke Munekage , Kazuhito Kawata , Tsubasa Tsutsumi , Koji Sawada , Tatsuji Maeshiro , Hiroshi Tobita , Yuichi Yoshida , Masafumi Naito , Asuka Araki , Shingo Arakaki , Takumi Kawaguchi , Hidenao Noritake , Masafumi Ono , Tsutomu Masaki , Satoshi Yasuda , Eiichi Tomita , Masato Yoneda , Akihiro Tokushige , Yoshihiro Kamada , Hirokazu Takahashi , Shinichiro Ueda , Shinichi Aishima , Yoshio Sumida , Takeshi Okanoue , Atsushi Nakajima crossref（2024）
AI 理解论文
溯源树
样例
